NRAS and leukemia: The cells were generated by knocking out endogenous NRAS with CRISPR/Cas9 and introducing an exogenous Dox-regulated NRASG12V expression vector into leukemia cells carrying the NRASG12D mutation and whose growth depended on the NRAS signaling pathway [11].